Scarborough Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1815355
ANNAPOLIS, MD
Position in VRTX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$20,987
-$320 QoQ
Shares Held
47
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Scarborough Advisors, LLC holds $13,652 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRDF |
Cardiff Oncology, Inc.
|
10,502 | $13,652 |
All Filings in VRTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,987 | 47 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $21,307 | 47 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,232 | 44 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $19,588 | 44 | Shares | Sole | 2025-08-05 | |
| 2024-06-30 | $7,030 | 15 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,270 | 15 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,696 | 14 | Shares | Sole | 2024-02-29 | |
| No filing history on record for this holder in this stock. | ||||||